A Research Study, Looking at the Characterization of Treatment Intensified (Add on to Metformin) Real-world Adult Population With Type 2 Diabetes Mellitus in India, Pakistan and Thailand. (CONVERGE)
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
This study aims to describe demographics, clinical, treatment and healthcare resource utilization characteristics with a particular focus on those relating to cardiovascular disease in selected treatment intensified patients with type 2 diabetes in the real-world settings in India, Pakistan, and Thailand.
The study will be based on data already recorded in participants medical record and no new tests or procedures are required as part of the study.
The study will last for about 6 months and it does not affect participants current treatment.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Male or female, age above or equal to 18 years at type 2 diabetes mellitus (T2DM) diagnosis
- Year of birth 1928 or later (age blow 90 years old in 2017)
- T2DM diagnosis in medical record on or after the date of local GLP-1 RA marketing authorization
- Medical records documenting prior or ongoing treatment with metformin
- Medical records documenting treatment with other non-metformin T2DM drugs
Exclusion criteria
- Previous participation in this study. Participation is defined as having given informed consent in this study.
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.
- Patients with any diagnosis of type 1 diabetes mellitus (T1DM)
Trial design
3,000 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal